Clinical trial
Rituximab for Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (RAVE) Long-Term Follow-Up Study
NCT01586858 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rituximab for Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (RAVE) Long-Term Follow-Up Study
- Lead sponsor
- Johns Hopkins University
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 31, 2012
- Completion date
- May 15, 2014
- Enrollment
- 67 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.